Similarly, inhibition of sEH activity by t-AUCB prevented hyperglycemia in a streptozotocin-induced T1D model, prevented islet β cell damage and improved glucose homeostasis [93]. The gene discussed is EPHX2; the disease is type 1 diabetes mellitus.